Evoke Pharma Inc
NASDAQ:EVOK

Watchlist Manager
Evoke Pharma Inc Logo
Evoke Pharma Inc
NASDAQ:EVOK
Watchlist
Price: 3.6117 USD 2.62% Market Closed
Market Cap: 5.4m USD
Section:
Wall Street Price Targets
Wall Street Price Targets
Revenue Forecast
Operating Income Forecast
Net Income Forecast
See Also
Price Target
Loading...
Revenue
Loading...
Operating Income
Loading...
Net Income
Loading...

Wall Street
Price Targets

EVOK Price Targets Summary
Evoke Pharma Inc

Wall Street analysts forecast EVOK stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for EVOK is 18.36 USD with a low forecast of 18.18 USD and a high forecast of 18.9 USD.

EVOK Lowest Forecast
Wall Street Target
18.18 USD
403% Upside
EVOK Average Forecast
Wall Street Target
18.36 USD
408% Upside
EVOK Highest Forecast
Wall Street Target
18.9 USD
423% Upside
Lowest
Price Target
18.18 USD
403% Upside
Average
Price Target
18.36 USD
408% Upside
Highest
Price Target
18.9 USD
423% Upside
Evoke Pharma Inc Competitors:
Price Targets
AJANTPHARM
Ajanta Pharma Ltd
22% Upside
4523
Eisai Co Ltd
35% Upside
PBH
Prestige Consumer Healthcare Inc
7% Upside
128940
Hanmi Pharm Co Ltd
15% Upside
AJANTPHARM
Ajanta Pharma Ltd
22% Upside
4523
Eisai Co Ltd
35% Upside
PBH
Prestige Consumer Healthcare Inc
7% Upside
128940
Hanmi Pharm Co Ltd
15% Upside
CIPLA
Cipla Ltd
13% Upside
000423
Dong-E-E-Jiao Co Ltd
42% Upside
SOLARA
Solara Active Pharma Sciences Ltd
20% Upside
GLAXO
GlaxoSmithKline Pharmaceuticals Ltd
19% Downside

Revenue
Forecast

Revenue Estimate
Evoke Pharma Inc

The compound annual growth rate of Evoke Pharma Inc's revenue for the next 3 years is 52%.

N/A
Past Growth
52%
Estimated Growth
Estimates Accuracy
-5%
Average Miss
What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
Evoke Pharma Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-5%
Average Miss
What are analyst estimates?

Net Income
Forecast

Net Income Estimate
Evoke Pharma Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-89%
Average Miss
What are analyst estimates?

See Also

Summary
EVOK intrinsic value, competitors valuation, and company profile.
DCF Valuation
EVOK stock valuation using Discount Cash Flow valuation method.
Relative Valuation
EVOK stock valuation using valuation multiples.
Wall Street Estimates
EVOK price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
EVOK stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is EVOK's stock price target?
Price Target
18.36 USD

According to Wall Street analysts, the average 1-year price target for EVOK is 18.36 USD with a low forecast of 18.18 USD and a high forecast of 18.9 USD.

What is Evoke Pharma Inc's Revenue forecast?
Projected CAGR
52%

The compound annual growth rate of Evoke Pharma Inc's revenue for the next 3 years is 52%.

Back to Top
ALPHA SPREAD
Follow us
Join more than 258,400+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.